...
首页> 外文期刊>Transfusion: The Journal of the American Association of Blood Banks >Removal of prion challenge from an immune globulin preparation by use of a size-exclusion filter.
【24h】

Removal of prion challenge from an immune globulin preparation by use of a size-exclusion filter.

机译:通过使用尺寸排阻过滤器从免疫球蛋白制剂中去除病毒激发。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: A size-exclusion filter (Viresolve 180, Millipore Corp.) was tested for its ability to remove transmissible spongiform encephalopathies prion protein from an immune globulin preparation during ultrafiltration. STUDY DESIGN AND METHODS: Hamster-adapted 263K scrapie brain homogenate (SBH) was spiked into Rh0(D) immune globulin (human) at 1 in 300 and 1 in 1000 dilutions. Before spiking, the SBH was treated with detergent, sonicated, and filtered through serial 0.45-, 0.22-, and 0.1-microm filters to present a rigorous filter challenge. Process variables were monitored throughout the ultrafiltration to ensure that the spiked material did not compromise the membrane flux. Removal of scrapie prion protein (PrP(Sc)) material was determined by use of a sensitive Western blot assay. RESULTS: The turbid SBH became completely translucent after sonication and passage through the 0.45-, 0.22-, and 0.1-microm filters. The filtration of the immune globulin containing PrP(Sc) material was more difficult to perform than was filtration of immune globulin spiked with the normal cellular isoform. Even during tangential flow filtration, the fibril material prevented the PrP(Sc)-spiked immune globulin from passing as readily through the filter. Western blot results indicated a removal of greater than or equal to 2.5 log PrP(Sc), while remaining within the normal filtration limits. CONCLUSIONS: The composition, physical condition, and the amount of SBH introduced have significant effects on the filtration of the immune globulin and the log removal values obtained. By use of a detergent-treated, sonicated, and filtered preparation of SBH, it was demonstrated that the Viresolve 180 effectively removes PrP(Sc) from the immune globulin.
机译:背景:对尺寸排阻过滤器(Viresolve 180,Millipore Corp.)进行了测试,该过滤器具有在超滤过程中从免疫球蛋白制剂中去除可传播的海绵状脑病病毒蛋白的能力。研究设计和方法:将适应仓鼠的263K瘙痒性脑匀浆(SBH)掺入Rh0(D)免疫球蛋白(人),稀释比例为300:1和1000:1。在加标之前,将SBH用去污剂处理,超声处理,并通过一系列0.45、0.22和0.1微米的过滤器过滤,以应对严峻的过滤挑战。在整个超滤过程中对过程变量进行监控,以确保加标的材料不会影响膜通量。通过使用敏感的蛋白质印迹分析确定刮scrap病毒蛋白(PrP(Sc))材料的去除。结果:浑浊的SBH经过超声处理并通过0.45、0.22和0.1微米的过滤器后变得完全透明。含有免疫球蛋白的PrP(Sc)物质的过滤比掺有正常细胞同工型的免疫球蛋白的过滤更困难。即使在切向流过滤过程中,原纤维材料也阻止了掺有PrP(Sc)的免疫球蛋白容易通过过滤器。 Western印迹结果表明去除率大于或等于2.5 log PrP(Sc),同时仍在正常过滤范围内。结论:SBH的组成,身体状况和添加量对免疫球蛋白的过滤和获得的对数去除值有重要影响。通过使用去污剂处理,超声处理和过滤的SBH制剂,证明Viresolve 180有效地从免疫球蛋白中去除了PrP(Sc)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号